Pure Global

Insulin pen type syringe Novo Pen 4 - Taiwan Registration b8b5fdb1c8de8fdd436c738d4a64a145

Access comprehensive regulatory information for Insulin pen type syringe Novo Pen 4 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number b8b5fdb1c8de8fdd436c738d4a64a145 and manufactured by NOVO NORDISK A/S;; NOVO NORDISK (CHINA) PHARMACEUTICALS CO., LTD.. The authorized representative in Taiwan is NOVO NORDISK PHARMA (TAIWAN) LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
b8b5fdb1c8de8fdd436c738d4a64a145
Registration Details
Taiwan FDA Registration: b8b5fdb1c8de8fdd436c738d4a64a145
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Insulin pen type syringe Novo Pen 4
TW: ่ƒฐๅณถ็ด ็ญ†ๅž‹ๆณจๅฐ„ๅ™จ่ซพๅ’Œ็ญ†4
Risk Class 2

Registration Details

b8b5fdb1c8de8fdd436c738d4a64a145

DHA04200026309

Company Information

Product Details

For details, it is Chinese approved copy of the imitation order

J General hospital and personal use equipment

J.5860 ๆดปๅกžๅผๆณจๅฐ„็ญ’;; J.6920 ๆณจๅฐ„้‡ๅฐŽๅผ•ๅ™จ

Chinese goods;; input

Dates and Status

May 14, 2010

May 14, 2025